The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Goldberg, H. L.
* Articles by Finnerty, R. J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Goldberg, H. L.
* Articles by Finnerty, R. J.

Am J Psychiatry 1979; 136:1184-1187
Copyright © 1979 by American Psychiatric Association


BRIEF REPORTS

The comparative efficacy of buspirone and diazepam in the treatment of anxiety

HL Goldberg and RJ Finnerty

In this double-blind study, 56 adult psychoneurotic outpatients with a primary diagnosis of anxiety neurosis were randomly assigned to receive buspirone (N = 18), diazepam (N = 20), or placebo (N = 18) over a four- week period. A battery of tests administered weekly indicated that buspirone, a new agent not chemically related to any currently marketed drugs, was as effective an antianxiety agent as diazepam and produced no more and perhaps fewer side effects. Buspirone showed excellent antidepressant effects as well. If further studies confirm the authors' findings and determine that buspirone does not result in tolerance and addiction, it would be more advantageous than the benzodiazepines in the treatment of anxiety.


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
S. R. Chamberlain, U. Muller, J. B. Deakin, P. R. Corlett, J. Dowson, R. N. Cardinal, M. R. F. Aitken, T. W. Robbins, and B. J. Sahakian
Lack of deleterious effects of buspirone on cognition in healthy male volunteers
J Psychopharmacol, March 1, 2007; 21(2): 210 - 215.
[Abstract] [PDF]


Home page
Drug Metab. Dispos.Home page
N. Raghavan, D. Zhang, M. Zhu, J. Zeng, and L. Christopher
CYP2D6 CATALYZES 5-HYDROXYLATION OF 1-(2-PYRIMIDINYL)-PIPERAZINE, AN ACTIVE METABOLITE OF SEVERAL PSYCHOACTIVE DRUGS, IN HUMAN LIVER MICROSOMES
Drug Metab. Dispos., February 1, 2005; 33(2): 203 - 208.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
E. A. Hoge, J. E. Oppenheimer, and N. M. Simon
Generalized Anxiety Disorder
Focus, July 1, 2004; 2(3): 346 - 359.
[Full Text] [PDF]


Home page
NeurologyHome page
I. Savic, P. Lindstrom, B. Gulyas, C. Halldin, B. Andree, and L. Farde
Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy
Neurology, April 27, 2004; 62(8): 1343 - 1351.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Renyi, J. L. Evenden, C. J. Fowler, E. Jerning, D. Kelder, D. Lake-Bakaar, L.-G. Larsson, N. Mohell, M. Sallemark, and S. B. Ross
The Pharmacological Profile of (R)-3,4-Dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide, a Selective 5-Hydroxytryptamine1A Receptor Agonist
J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 883 - 893.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. A. Vanecek, W. D. Essman, D. P. Taylor, and J. H. Woods
Discriminative Stimulus Characteristics of BMY 14802 in the Pigeon
J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 1 - 9.
[Abstract] [Full Text]


Home page
J PsychopharmacolHome page
X.-o. Zhu and N. McNaughton
Similar effects of buspirone and chlordiazepoxide on a fixed interval schedule with long-term, low-dose administration
J Psychopharmacol, January 1, 1995; 9(4): 326 - 330.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
J.F.W. Deakin
A review of clinical efficacy of 5-HT 1A agonists in anxiety and depression
J Psychopharmacol, January 1, 1993; 7(3): 283 - 289.
[PDF]


Home page
J PsychopharmacolHome page
A. Rex, C.A. Marsden, and H. Fink
5-HT 1A receptors and changes in extracellular 5-HT in the guinea-pig prefrontal cortex: involvement in aversive behaviour
J Psychopharmacol, January 1, 1993; 7(4): 338 - 345.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
K. S. Panickar and N. McNaughton
Effects of buspirone on fixed interval responding in rats
J Psychopharmacol, January 1, 1991; 5(4): 410 - 417.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
E. Przegalinski, E. Tatarczynska, and E. Chojnacka-Wojcik
Anticonflict effect of ipsapirone, buspirone and gepirone is not mediated by their common metabolite 1-(2-pyrimidinyl)piperazine
J Psychopharmacol, January 1, 1989; 3(3): 180 - 185.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
C.T. Dourish, G.A. Kennett, and G. Curzon
The 5-HT1A agonists 8-OH-DPAT, buspirone and ipsapirone attenuate stress-induced anorexia in rats
J Psychopharmacol, January 1, 1987; 1(1): 23 - 30.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1979 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org